Prevalence of Prone Positioning Use in ARDS Patients

Overview

Prone positioning has been shown to improve survival in patients with acute respiratory distress syndrome (ARDS). However, a recent large observational study found that prone positioning was used in only 7% of all ARDS patients, and 16% in the severe category. However, this study did not focus on the prone position per se. In present study, the investigators would like to explore the rate of use of prone positioning in ARDS patients and the reasons why this treatment was not applied. The present study is one-day prevalence study repeated four times over one year. The hypothesis is that the rate of use of prone position is greater than 50% in the severe ARDS category.

Full Title of Study: “Prospective Study on the Prevalence on the Use of Prone Positioning in ARDS Patients”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 2017

Interventions

  • Procedure: Prone positioning
    • Turning the patient face down for several consecutive hours

Arms, Groups and Cohorts

  • ARDS patients receiving invasive mechanical ventilation in ICU
    • ARDS criteria (Berlin definition) fulfilled the day of the study, whatever the ARDS stage. The onset of ARDS could have been established at any time between ICU admission and study day but ARDS criteria must be still present the day of the study. The ARDS criteria are listed below Within 1 week of a known clinical insult or new or worsening respiratory symptoms Bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules Respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present PaO2/FIO2 ≤ 300 with Positive end-expiratory pressure (PEEP) ≥ 5 cmH2O Age ≥ 18 years Intubated or tracheotomized and mechanically ventilated

Clinical Trial Outcome Measures

Primary Measures

  • Prevalence of the use of the prone position in ARDS
    • Time Frame: Day 1
    • Number of patients with ARDS receiving prone position divided by number of patients with ARDS on the day of the study

Secondary Measures

  • Prevalence of the use of the prone position in each ARDS category
    • Time Frame: Day 1
    • Number of patients with ARDS in each category receiving prone position divided by number of patients with ARDS in each category on the day of the study
  • Occurence of reasons for not using prone position in ARDS patients
    • Time Frame: Day 1
    • Reasons: No severe hypoxemia for the clinician, Intracranial hypertension, Mean arterial pressure < 65 mmHg, Unstable fractures, Pneumothorax with previous single drain, External cardiac stimulation or internal pacemaker inserted for less than 48 hours, Tracheotomy for less than 15 days (not for access to airways for the current mechanical ventilation purpose), Severe facial trauma or facial surgery in the last 15 days, Sternotomy in the last 15 days, Venous thrombosis treated by anticoagulant molecule for less than 48 hours, Massive hemoptysis requiring interventional radiology or other emergency procedure, Pregnant woman, Excess in workload, Other reason
  • PaO2
    • Time Frame: Day 1
    • oxygenation (PaO2) to assess the physiological response to the prone position session
  • PaO2/FIO2
    • Time Frame: Day 1
    • oxygenation (PaO2/FIO2) to assess the physiological response to the prone position session
  • Duration of prone position session
    • Time Frame: Day 1
    • Difference between time of onset to time of end (consecutive hours)

Participating in This Clinical Trial

Inclusion Criteria

  • 1.ARDS criteria (Berlin definition) fulfilled the day of the study, whatever the ARDS stage. The onset of ARDS could have been established at any time between ICU admission and study day but ARDS criteria must be still present the day of the study. The ARDS criteria are listed below – Within 1 week of a known clinical insult or new or worsening respiratory symptoms – Bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules – Respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present – 2.PaO2/FIO2 ≤ 300 with PEEP ≥ 5 cmH2O – 3.Age ≥ 18 years – 4.Intubated or tracheotomized and mechanically ventilated Exclusion Criteria:

  • Patient non intubated the day of the study – No criteria for ARDS the day of the study even if these criteria were present between ICU admission and day of the study

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hospices Civils de Lyon
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Claude Guérin, Pr, Principal Investigator, Réanimation médicale, Hôpital de la Croix Rousse, CHU de Lyon, France

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.